Role of aromatic side chains in amyloid β-protein aggregation.

N-Terminal Extensions Retard Aβ42 Fibril Formation but Allow Cross-Seeding and Coaggregation with Aβ42. J Am Chem Soc (2015) 0.81

A critical role for the self-assembly of Amyloid-β1-42 in neurodegeneration. Sci Rep (2016) 0.78

Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide. Sci Rep (2016) 0.78

Fluorescent filter-trap assay for amyloid fibril formation kinetics in complex solutions. ACS Chem Neurosci (2015) 0.78

Assembly of Peptides Derived from β-Sheet Regions of β-Amyloid. J Am Chem Soc (2016) 0.77

Melanosomal formation of PMEL core amyloid is driven by aromatic residues. Sci Rep (2017) 0.75

The diversity and utility of amyloid fibrils formed by short amyloidogenic peptides. Interface Focus (2017) 0.75

Amyloidogenic motifs revealed by n-gram analysis. Sci Rep (2017) 0.75

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51

A beta oligomers - a decade of discovery. J Neurochem (2007) 8.88

The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21

Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry (2006) 6.54

Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci (2007) 6.27

Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci (1991) 5.71

Translating cell biology into therapeutic advances in Alzheimer's disease. Nature (1999) 5.42

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem (1997) 5.07

Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88

Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem (1989) 4.43

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17

Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol (2010) 3.75

A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J (2002) 3.34

Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des (2006) 3.04

Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron (2011) 2.67

Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev (2010) 2.64

Context is a major determinant of beta-sheet propensity. Nature (1994) 2.53

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem (1996) 2.34

Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta (2010) 2.22

A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem (1999) 2.12

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging (2005) 2.11

Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry (1995) 2.05

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J Mol Biol (1992) 1.90

Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci (2008) 1.86

A new structural model of Aβ40 fibrils. J Am Chem Soc (2011) 1.78

Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem (2004) 1.78

Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75

From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol (2012) 1.71

A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J (2009) 1.71

The origins of Alzheimer disease: a is for amyloid. JAMA (2000) 1.67

Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry (1996) 1.58

Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci (2005) 1.56

Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry (2001) 1.54

Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Proc Natl Acad Sci U S A (2006) 1.44

The chemistry of Alzheimer's disease. Chem Soc Rev (2009) 1.40

Experimental measures of amino acid hydrophobicity and the topology of transmembrane and globular proteins. J Gen Physiol (2007) 1.35

Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. FEBS J (2006) 1.29

Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species. J Biol Chem (2010) 1.28

Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide. J Biol Chem (2003) 1.10

Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10

Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. PLoS One (2010) 1.06

Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide. Biophys J (2007) 0.98

Differential effects of Phe19 and Phe20 on fibril formation by amyloidogenic peptide A beta 16-22 (Ac-KLVFFAE-NH2). Proteins (2010) 0.92

Flow-induced alignment of amyloid protofilaments revealed by linear dichroism. J Biol Chem (2007) 0.92

Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide. Biochemistry (2011) 0.92

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50

Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41

Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A (2011) 3.11

Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89

Methods for the detection and analysis of protein-protein interactions. Proteomics (2007) 2.29

The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22

Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02

The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol (2012) 1.93

Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75

A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J (2009) 1.71

Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60

Structure and functional properties of the Bacillus subtilis transcriptional repressor Rex. Mol Microbiol (2008) 1.49

Correlation between sperm motility and sperm chromatin structure assay parameters. Fertil Steril (2003) 1.49

Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47

Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37

Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34

Measurement of Ca2+-binding constants of proteins and presentation of the CaLigator software. Anal Biochem (2002) 1.34

Calbindin D28k exhibits properties characteristic of a Ca2+ sensor. J Biol Chem (2002) 1.29

Physical properties of type I collagen extracted from fish scales of Pagrus major and Oreochromis niloticas. Int J Biol Macromol (2003) 1.27

Residue-specific pKa determination of lysine and arginine side chains by indirect 15N and 13C NMR spectroscopy: application to apo calmodulin. J Am Chem Soc (2007) 1.25

Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol (2004) 1.24

140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res (2006) 1.21

The EF-hand domain: a globally cooperative structural unit. Protein Sci (2002) 1.17

Microstructure, mechanical, and biomimetic properties of fish scales from Pagrus major. J Struct Biol (2003) 1.16

Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14

Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J (2007) 1.09

Protein reconstitution and three-dimensional domain swapping: benefits and constraints of covalency. Protein Sci (2007) 1.08

Metal sulfide nanoparticles synthesized via enzyme treatment of biopolymer stabilized nanosuspensions. Nanoscale (2009) 1.07

Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J Immunol (2002) 1.06

Surface effects on aggregation kinetics of amyloidogenic peptides. J Am Chem Soc (2014) 1.06

Calmodulin binding to the polybasic C-termini of STIM proteins involved in store-operated calcium entry. Biochemistry (2008) 1.06

The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelins. J Immunol (2008) 1.05

HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects. Adv Cancer Res (2003) 1.05

Salting the charged surface: pH and salt dependence of protein G B1 stability. Biophys J (2006) 1.05

Myo-inositol monophosphatase is an activated target of calbindin D28k. J Biol Chem (2002) 1.05

Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. J Am Chem Soc (2013) 1.03

Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J Biol Chem (2002) 1.03

High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One (2012) 1.01

pK(a) values for side-chain carboxyl groups of a PGB1 variant explain salt and pH-dependent stability. Biophys J (2006) 1.00

Membrane interaction of α-synuclein in different aggregation states. J Parkinsons Dis (2011) 0.98

The role of electrostatic interactions in calmodulin-peptide complex formation. Biophys J (2004) 0.98

Lipids as cofactors in protein folding: stereo-specific lipid-protein interactions are required to form HAMLET (human alpha-lactalbumin made lethal to tumor cells). Protein Sci (2003) 0.98

On the lag phase in amyloid fibril formation. Phys Chem Chem Phys (2015) 0.98

Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem J (2005) 0.97

Coupling of ligand binding and dimerization of helix-loop-helix peptides: spectroscopic and sedimentation analyses of calbindin D9k EF-hands. Proteins (2002) 0.97

BRICHOS domains efficiently delay fibrillation of amyloid β-peptide. J Biol Chem (2012) 0.97

Structural changes in apolipoproteins bound to nanoparticles. Langmuir (2011) 0.96

100% complete assignment of non-labile (1)H, (13)C, and (15)N signals for calcium-loaded Calbindin D(9k) P43G. Biomol NMR Assign (2010) 0.96

Amino acid synergetic effect on structure, morphology and surface properties of biomimetic apatite nanocrystals. Acta Biomater (2008) 0.96

Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog (2006) 0.96

Protein reconstitution and 3D domain swapping. Curr Protein Pept Sci (2002) 0.93

Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases. J Neurochem (2008) 0.93

Standards for nurse staffing in critical care units determined by: The British Association of Critical Care Nurses, The Critical Care Networks National Nurse Leads, Royal College of Nursing Critical Care and In-flight Forum. Nurs Crit Care (2010) 0.93

Electrostatic contributions to residue-specific protonation equilibria and proton binding capacitance for a small protein. Biochemistry (2006) 0.92

Intramolecular dynamics of low molecular weight protein tyrosine phosphatase in monomer-dimer equilibrium studied by NMR: a model for changes in dynamics upon target binding. J Mol Biol (2002) 0.91

Acute aortic dissection. BMJ (2011) 0.90

Calcium binding, structural stability and guanylate cyclase activation in GCAP1 variants associated with human cone dystrophy. Cell Mol Life Sci (2010) 0.89

Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. ACS Chem Neurosci (2013) 0.89

A proline-rich region with a highly periodic sequence in Streptococcal beta protein adopts the polyproline II structure and is exposed on the bacterial surface. J Bacteriol (2002) 0.89

Multi-method global analysis of thermodynamics and kinetics in reconstitution of monellin. Proteins (2004) 0.88

Salt enhances calmodulin-target interaction. Biophys J (2006) 0.88

The BRICHOS domain, amyloid fibril formation, and their relationship. Biochemistry (2013) 0.88

Electrostatic contributions to the kinetics and thermodynamics of protein assembly. Biophys J (2004) 0.87

Redox sensitive cysteine residues in calbindin D28k are structurally and functionally important. Biochemistry (2005) 0.87

Monte Carlo simulations of protein amyloid formation reveal origin of sigmoidal aggregation kinetics. Mol Biosyst (2011) 0.87

Calcium binding and thermostability of carbohydrate binding module CBM4-2 of Xyn10A from Rhodothermus marinus. Biochemistry (2002) 0.87

Intra- versus intermolecular interactions in monellin: contribution of surface charges to protein assembly. J Mol Biol (2006) 0.87

British Association of Critical Care Nurses position statement on the use of restraint in adult critical care units. Nurs Crit Care (2004) 0.87

Reconstitution of calmodulin from domains and subdomains: Influence of target peptide. J Mol Biol (2006) 0.87

Augmentation of skeletal tissue formation in impaction bone grafting using vaterite microsphere biocomposites. Biomaterials (2009) 0.87

Alpha-lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Protein Sci (2003) 0.87

Deamidation and disulfide bridge formation in human calbindin D28k with effects on calcium binding. Protein Sci (2005) 0.86

gamma-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neurons. Brain Res (2009) 0.86

Integrated protein array screening and high throughput validation of 70 novel neural calmodulin-binding proteins. Mol Cell Proteomics (2010) 0.86

Charge dependent retardation of amyloid β aggregation by hydrophilic proteins. ACS Chem Neurosci (2014) 0.85

Effects of metal-binding loop mutations on ligand binding to calcium- and integrin-binding protein 1. Evolution of the EF-hand? Biochemistry (2008) 0.85

Solution structure of the Ca2+-Binding EGF3-4 pair from vitamin K-dependent protein S: identification of an unusual fold in EGF3. Biochemistry (2005) 0.85

Dynamics of conformational Ca2+-switches in signaling networks detected by a planar plasmonic device. Anal Chem (2012) 0.85

Identification of a high-affinity network of secretagogin-binding proteins involved in vesicle secretion. Mol Biosyst (2011) 0.85

Role of protein surface charge in monellin sweetness. Biochim Biophys Acta (2008) 0.84

Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening. Nanomedicine (2012) 0.84

Hamlet--a complex from human milk that induces apoptosis in tumor cells but spares healthy cells. Adv Exp Med Biol (2002) 0.84

Calmodulin transduces Ca2+ oscillations into differential regulation of its target proteins. ACS Chem Neurosci (2013) 0.83